MCK Jan 2024 200.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:32AM EST. Market open.
| Previous close | 0.2500 |
| Open | 0.2500 |
| Bid | 0.0000 |
| Ask | 0.9500 |
| Strike | 200.00 |
| Expiry date | 2024-01-19 |
| Day's range | 0.2500 - 0.2500 |
| Contract range | N/A |
| Volume | |
| Open interest | 64 |
Motley FoolThis 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
Bigtime medical distributors like McKesson (NYSE: MCK) and Cencora (NYSE: COR) make money by moving drugs and supplies to clinics and pharmacies worldwide. If you guessed Ozempic, the medication made by Novo Nordisk for type 2 diabetes, you're correct. Along with the drug's other formulations called Wegovy and Rybelsus, which are indicated for helping people to lose weight, Ozempic belongs to a class of medications called GLP-1 agonists.
ZacksMcKesson (MCK) Announces Availability of FDA-Cleared Drug
The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for breast cancer.
ZacksMcKesson (MCK) Up 5.1% Since Last Earnings Report: Can It Continue?
McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2023 Yahoo. All rights reserved.